Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pineda

Showing results (351-360 of 395) with videos related to

Pageof 40
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|June 11, 2021
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery diseaseFrancesco Franchi, Fabiana Rollini, Latonya Been, et al.
JACC. Cardiovascular Interventions|November 1, 2022
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 StudyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.
American Journal of Human Genetics|October 31, 2000
Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesisL W Klomp, T J de Koning, H E Malingré, et al.
JACC. Heart Failure|February 28, 2025
Left Atrial-to-Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT-FLOW Trial (Early Feasibility Study) 2-Year ResultsFrancesco Fioretti, Benjamin Hibbert, Peter M Eckman, et al.
Nature|February 3, 2015
Mitochondrial DNA stress primes the antiviral innate immune responseA Phillip West, William Khoury-Hanold, Matthew Staron, et al.
Cell|July 23, 2013
KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumorsJoshua C Black, Amity L Manning, Capucine Van Rechem, et al.
Circulation|January 12, 2019
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionFrancesco Franchi, Fabiana Rollini, Andrea Rivas, et al.
JACC. Basic to Translational Science|June 2, 2020
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic TestingFrancesco Franchi, Fabiana Rollini, Jose Rivas, et al.
Plos One|November 13, 2015
HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral TherapySantiago Avila-Ríos, Claudia García-Morales, Daniela Tapia-Trejo, et al.
Familial Cancer|July 3, 2020
Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019M Suerink, K Wimmer, L Brugieres, et al.
Pageof 40

Showing results (351-360 of 395) with videos related to

Sort By:
Pageof 40
European Heart Journal. Cardiovascular Pharmacotherapy|June 11, 2021
Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery diseaseFrancesco Franchi, Fabiana Rollini, Latonya Been, et al.
JACC. Cardiovascular Interventions|November 1, 2022
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 StudyFrancesco Franchi, Luis Ortega-Paz, Fabiana Rollini, et al.
American Journal of Human Genetics|October 31, 2000
Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency--a neurometabolic disorder associated with reduced L-serine biosynthesisL W Klomp, T J de Koning, H E Malingré, et al.
JACC. Heart Failure|February 28, 2025
Left Atrial-to-Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT-FLOW Trial (Early Feasibility Study) 2-Year ResultsFrancesco Fioretti, Benjamin Hibbert, Peter M Eckman, et al.
Nature|February 3, 2015
Mitochondrial DNA stress primes the antiviral innate immune responseA Phillip West, William Khoury-Hanold, Matthew Staron, et al.
Cell|July 23, 2013
KDM4A lysine demethylase induces site-specific copy gain and rereplication of regions amplified in tumorsJoshua C Black, Amity L Manning, Capucine Van Rechem, et al.
Circulation|January 12, 2019
Platelet Inhibition With Cangrelor and Crushed Ticagrelor in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionFrancesco Franchi, Fabiana Rollini, Andrea Rivas, et al.
JACC. Basic to Translational Science|June 2, 2020
Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic TestingFrancesco Franchi, Fabiana Rollini, Jose Rivas, et al.
Plos One|November 13, 2015
HIV Drug Resistance Surveillance in Honduras after a Decade of Widespread Antiretroviral TherapySantiago Avila-Ríos, Claudia García-Morales, Daniela Tapia-Trejo, et al.
Familial Cancer|July 3, 2020
Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019M Suerink, K Wimmer, L Brugieres, et al.
Pageof 40